Soluble Axl (sAxl) has emerged as a promising biomarker for the early detection, diagnosis, and monitoring of various cancers [10], including pancreatic ductal adenocarcinoma [12], hepatocellular carcinoma [11, 15], and melanoma [13]. The gene discussed is AXL; the disease is hepatocellular carcinoma.